Pharming Group NV (PHAR) Social Stream
Pharming Group NV (PHAR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PHAR.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
PHAR Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, Pharming Group NV's number of analysts covering the stock is higher than 9.36% of them.
- In terms of how Pharming Group NV fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 89.33% of that group.
- Pharming Group NV's upside potential (average analyst target price relative to current price) is higher than 257.7% of stocks in the small market cap category.
- In the context of stocks in the small market cap category, Pharming Group NV's average analyst price target is greater than 246.52% of them.
Is PHAR a Buy, Hold or Sell? See the POWR Ratings now!